XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

FINANCIAL ASSETS AND FINANCIAL LIABILITIES | 12 Months Ended
--- | ---
Dec. 31, 2023
Disclosure of detailed information about financial instruments [abstract] |
FINANCIAL ASSETS AND FINANCIAL LIABILITIES | FINANCIAL ASSETS AND FINANCIAL LIABILITIES 11(a) Other financial assets and liabilities
| As of December 31,
| 2023 |  | 2022
| US$’000 |  | US$’000
Financial assets at fair value through other comprehensive income |  |  |
Equity instrument (Note 11(d)) | 2,902 |  |  | 1,553 |
| 2,902 |  |  | 1,553 |
Financial assets at fair value through profit or loss |  |  |
Foreign exchange forward contracts (Note 11(c)) | 307 |  |  | 39 |
| 307 |  |  | 39 |
(i)Financial assets and liabilities at fair value through profit or loss Financial assets and liabilities at fair value through profit or loss reflect the changes in fair value of those foreign exchange forward contracts that are not designated in hedge relationships, but are intended to reduce the level of foreign currency risk for expected sales and purchase transactions. (ii)Financial assets at fair value through other comprehensive income - unquoted equity instrument Our Company holds unquoted equity instruments in Thai Metal Processing Co., Ltd., which is engaged in the fabrication of copper rods, and Leijyu Co., Ltd., which is engaged in the development of a renewable energy power generation system. These equity investments are strategically held for long-term purposes and are not expected to be sold in the short to medium term. During the years ended December 31, 2023, 2022, and 2021, our Company received dividends of $97, $97, and $106, respectively, from investments held at the end of the reporting period. These dividends were recorded in other income (Note 7(f)) in the consolidated income statements. 11(b) Interest-bearing loans and borrowings Under the line of credit arrangements for short-term debt with our Company’s banks, our Company may borrow up to approximately $263,981 and $254,851 as of December 31, 2023 and 2022, respectively, on such terms as our Company and the banks may mutually agree upon. These arrangements do not have termination dates but are reviewed annually for renewal. As of December 31, 2023 and 2022, the unused portion of the credit lines was approximately $187,752 and $162,074, respectively, which included unused letters of credit amounting to $83,926 and $84,586, respectively. Letters of credit are issued by our Company in the ordinary course of business through major financial institutions as required by certain vendor contracts. As of December 31, 2023 and 2022, our Company had open letters of credit amounting to $38,179 and $38,256, respectively. Liabilities relating to the opened letters of credit are included in current liabilities. Certain of our loan agreements contain covenants that, if violated, could result in the obligations under these agreements becoming due prior to the originally scheduled maturity dates. Our Company was in compliance with these covenants requirements as of December 31, 2023 and 2022. Interest bearing loans and borrowings are including current portion $53,737 and $45,576 as of December 31, 2023 and 2022, respectively.
| As of December 31,
| 2023 |  | 2022
| Interest rate | Maturity | Local currency |  |  | Interest rate | Maturity | Local currency |
| % |  | ‘000 | US$’000 |  | % |  | ‘000 | US$’000
Interest-bearing loans and borrowings |  |  |  |  |  |  |  |  |
Bank loans | 4.94 | Nov. 2024 | AUD$4,543 | 3,104 |  |  | 4.94 | Mar. 2044 | AUD$4,589 | 3,113 |
Bank loans | — | — | — | — |  |  | 4.50 ~ 4.90 | Jul. 2023 | RMB$30,100 | 4,321 |
Bank loans | 5.11 | Dec. 2024 | SGD$6,000 | 4,551 |  |  | 5.42 | Dec. 2023 | SGD$6,000 | 4,470 |
Bank loans | 7.27 | Feb. 2024 | THB$309,488 | 9,090 |  |  | 2.23 | Feb. 2024 | THB$312,602 | 9,100 |
Trust receipt | 2.75 ~ 4.70 | May 2024 | THB$1,151,234 | 33,812 |  |  | 1.60 ~ 2.20 | Jun. 2023 | THB$1,133,838 | 33,006 |
Trust receipt | 5.46 ~ 5.61 | Apr. 2024 | SGD$4,193 | 3,180 |  |  | 5.04 ~5.81 | Apr. 2023 | SGD$4,994 | 3,721 |
Total |  |  |  | 53,737 |  |  |  |  |  | 57,731 |
11(c) Hedging activities and derivatives (i)Commodity price risk Our Company purchases copper on an ongoing basis as its operating activities require a continuous supply of copper for manufacturing products. To reduce the exposures to copper shortage, our Company enters into purchase contracts with commitment of monthly minimum purchase at market prices for selected operating units. The majority of these transactions take the form of contracts that are entered into and continue to be held for the purpose of receipt or delivery of the copper based on our Company’s expected purchase, sale or usage requirements. Such purchase commitment contracts are not deemed financial instruments or derivatives. To date, these contract positions have not had a material effect on our Company’s financial position, results of operations, and cash flow. (ii)Foreign currency risk Our Company enters into foreign exchange forward contracts with the intention to reduce the foreign exchange risk of expected sales and purchase transactions. These contracts are entered into the periods consistent with foreign currency exposure of the underlying transaction, generally from one to 12 months. These contracts are not designated in hedge relationships, and are measured at fair value through profit or loss. As of December 31, 2023 and 2022, our Company had outstanding forward contracts with notional amounts of $13.4 million and $10.5 million, respectively. The outstanding forward contracts at December 31, 2023 mature between January 13, 2024 and April 17, 2024, respectively. Our Company recognized gain (loss) on forward contracts as other income (expenses) – refer to Note 7(f). The forward contract balance varies with the expected foreign currency transactions and changes in foreign exchange rate.
| 2023 |  | 2022
| Assets |  | Liabilities |  | Assets |  | Liabilities
| US$’000 |  | US$’000 |  | US$’000 |  | US$’000
Foreign currency forward contracts |  |  |  |  |  |  |
Fair value | 307 |  |  | 74 |  |  | 39 |  |  | 6 |
11(d) Fair values Set out below is a comparison of the carrying amounts and fair value of our Company’s financial instruments that are carried in the financial statements:
| Carrying amount |  | Fair value
| As of December 31, |  | As of December 31,
| 2023 |  | 2022 |  | 2023 |  | 2022
| US$’000 |  | US$’000 |  | US$’000 |  | US$’000
Financial assets-current |  |  |  |  |  |  |
Financial assets at fair value through profit | 307 |  |  | 39 |  |  | 307 |  |  | 39 |
Financial assets at amortized cost |  |  |  |  |  |  |
Cash and cash equivalents | 37,970 |  |  | 54,017 |  |  | 37,970 |  |  | 54,017 |
Trade receivables | 104,955 |  |  | 81,982 |  |  | 104,955 |  |  | 81,982 |
Other receivables | 1,670 |  |  | 2,397 |  |  | 1,670 |  |  | 2,397 |
Due from related parties | 1,368 |  |  | 11,018 |  |  | 1,368 |  |  | 11,018 |
Financial assets-non-current |  |  |  |  |  |  |
Financial assets at fair value through other comprehensive income | 2,902 |  |  | 1,553 |  |  | 2,902 |  |  | 1,553 |
Financial assets at amortized cost |  |  |  |  |  |  |
Long-term bank deposits* | 1,454 |  |  | 1,354 |  |  | 1,454 |  |  | 1,354 |
Total | 150,626 |  |  | 152,360 |  |  | 150,626 |  |  | 152,360 |
Financial liabilities-current |  |  |  |  |  |  |
Liabilities at amortized cost |  |  |  |  |  |  |
Interest-bearing loans and borrowings | 53,737 |  |  | 45,576 |  |  | 53,737 |  |  | 45,576 |
Trade and other payables | 51,743 |  |  | 39,891 |  |  | 51,743 |  |  | 39,891 |
Due to related parties | 7,941 |  |  | 16,613 |  |  | 7,941 |  |  | 16,613 |
Accruals | 15,250 |  |  | 21,218 |  |  | 15,250 |  |  | 21,218 |
Financial liabilities-non-current |  |  |  |  |  |  |
Liabilities at amortized cost |  |  |  |  |  |  |
Interest-bearing loans and borrowings | — |  |  | 12,155 |  |  | — |  |  | 12,155 |
Total | 128,671 |  |  | 135,453 |  |  | 128,671 |  |  | 135,453 |
*included in other non-current assets (i)Methods and assumptions used to estimate fair value The fair value of the financial assets and liabilities is included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate the fair values: u Due to the short-term nature of financial assets and liabilities, including cash and cash equivalents, trade receivables, other receivables, due from related parties, trade and other payables, due to related parties, and accruals, their carrying amounts are considered to approximate their fair value. 11(d) Fair values (continued) (i)Methods and assumptions used to estimate fair value (continued) u Fixed-rate and variable-rate receivables are evaluated by our Company based on parameters such as interest rates, specific country risk factors, individual creditworthiness of the customer and the risk characteristics of the financed project. Based on this evaluation, allowances were provided to account for the expected losses of these receivables. As of December 31, 2023 and 2022, the carrying amounts of such receivables, net of allowances, were not materially different from their calculated fair values. u Fixed rate long-term bank deposits and fixed rate and variable-rate borrowings are evaluated using discounted cash flows and the market rates or current rates for deposits of similar remaining maturities. u Fair value of financial liabilities at fair value through profit or loss - derivatives is derived from inputs other than quoted prices that are observable for the asset or liability. u Fair value of interest-bearing borrowings and loans are determined by using discounted cash flow method with discount rate that reflects the issuer’s borrowing rate as of the end of the reporting period. The non-performance risk as of December 31, 2023 was assessed to be insignificant. (ii)Description of significant unobservable inputs to valuation
| Valuation technique | Significant unobservable inputs | Liquidity discount (2023 and 2022) |  | Sensitivity of the input to fair value
|  |  |  |  | 2023 | 2022
Financial asset |  |  |  |  |  |
Unquoted equity instrument | Market Approach Method | Liquidity Discount | 30% |  | 5% decrease in the discount would increase in fair value by $190 | 5% decrease in the discount would increase in fair value by $111
Our Company estimates the fair value of investment in equity instrument by using the market approach (market comparatives approach). The key in this method is the selection of quoted comparable companies and accommodate adjustments to bring the accounts of different companies into a broadly consistent framework for analysis. Then, select appropriate Indicators of Value. The followings should be taken into account: u Enterprise Value (EV) versus Market Capitalization; u Earnings-based: EBITDA +/or EBIT versus Net Earnings +/or Net Cash Flow u Balance Sheet based: Net Total Assets versus Shareholders Funds Discount for the lack of liquidity to reflect the lesser liquidity of this equity instrument compared with those of its comparable public company peers. Our Company assessed the discount for the lack of liquidity to be 30 percent on the basis of relevant studies applicable in the region and industry as well as on the specific facts and circumstances of the equity instrument. The equity instrument’s finance performance is characterized by stable, consistent growth and profitability. Our Company believes the liquidity discount of 30% would be appropriate. 11(d) Fair values (continued) (ii)Description of significant unobservable inputs to valuation (continued) Our Company carries the equity instrument as financial assets at fair value through other comprehensive income classified as level 3 in the fair value hierarchy. A reconciliation of the beginning and closing balances is summarized below:
| 2023 |  | 2022
| US$’000 |  | US$’000
At January 1 | 1,553 |  |  | 2,929 |
Acquisitions | 240 |  |  | — |
Recognized in other comprehensive income/(loss) | 1,104 |  |  | (1,352) |
Exchange difference on translation | 5 |  |  | (24) |
At December 31 | 2,902 |  |  | 1,553 |

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Section Scope -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration